A Novel NLRP3 Inhibitor AMS-17 Rescues Deficits in Long-Term Potentiation Following Mild Traumatic Brain Injury in Adult C57Bl/6 Mice
Study Overview The research focuses on investigating the effects of a novel NLRP3 inhibitor, AMS-17, on cognitive deficits resulting from […]
